Clinical Trial: A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07764237) titled 'A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults' on Aug. 10.

Brief Summary: The main objective of this trial is to evaluate the safety, reactogenicity, and immunogenicity of study interventions across intervention groups

Study Start Date: Aug. 16

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus (RSV) Human Metapneuomovirus (hMPV)

Intervention: BIOLOGICAL: mRNA-1365 (Profile 2)

Sterile liquid for injection

BIOLOGICAL: mRNA-1345 (Profile 1)

Sterile liquid for injection

BIOLOGICAL: mRNA-1345 (Profile 3)

Sterile liquid for injection

Recruitme...